Share
   
Title
Code
Session Type
Venue
Date Time
Co-Chairs:
14:30
MOAB0301
Hepatitis C care cascade for people living with HIV in the country of Georgia
Nikoloz Chkhartishvili, Georgia
Abstract
Slides
14:45
MOAB0302
Trends in cause-specific mortality in HIV-hepatitis C (HCV) co-infected patients in Canada (2003-2016): early impact of HCV therapy
Nadine Kronfli, Canada
Abstract
Slides
15:00
MOAB0303
Efficacy and safety of glecaprevir/pibrentasvir in patients co-infected with hepatitis C virus and human immunodeficiency virus-1: the EXPEDITION-2 study
Karine Lacombe, France
Abstract
Slides
15:15
MOAB0304
Metabolic syndrome and obesity are the cornerstones of liver fibrosis in HIV-monoinfected patients: results of the METAFIB study
Maud Lemoine, United Kingdom
Abstract
Slides
15:30
MOAB0305
Predictor factors associated with liver fibrosis and steatosis by transient elastography in HIV-monoinfected patients under long-term combined antiretroviral therapy: the PROSPEC-HIV study
Hugo Perazzo Pedroso Barbosa, Brazil
Abstract
Slides